Harlow et al, "Antibodies A Laboratory Manual", Cold Spring Harbor Laboratory 1988, pp. 274-275. |
Mercken et al., "Monoclonal Antibodies with Selective Specificity for Alzheimer Tau are Directed Against Phosphate-Sensitive Epitopes," pp. 265-272, Acta Neuropathologica, vol. 84, No. 6, Berlin, Germany (1992). |
Drewes et al., "Mitogen Activated Protein (MAP) Kinase Transforms Tau Protein into Alzheimer-like State," pp. 2131-2138, The EMBO Journal, vol. 11, No. 6, Oxford, England (Jun. 1992). |
Roder et. al., "Brain Protein Kinase PK40erk Converts Tau into a PHF-like Form as Found in Alzheimer's Disease," pp. 639-647, Biochemical and Biophysical Research Communications, vol. 193, No. 2, Duluth, Minnesota (Jun. 15, 1993). |
Hanger et al., "Glycogen Synthase Kinase-3 Induces Alzheimer's Disease-like Phosphorylation of Tau: Generation of Paired Helical Filament Epitopes and Neuronical Localization of the Kinase," pp. 58-62, Neuroscience Letters, vol. 147, No. 1, Shannon, Ireland (Nov. 23, 1992). |
Vandermeeren et al., "Detection of Tau Proteins in Normal and Alzheimer's Disease Cerebrospinal Fluid with a Sensitive Sandwich Enzyme-linked Immunosorbent Assay," pp. 1828-1834, Journal of Neurochemistry, vol.61, No. 8, New York, New York (Nov. 1993). |
Lichtenberg-Kragg et al., "Phosphorylation-dependent Epitopes of Neurofilament Anitbodies on Tau Protein and Relationship with Alzheimer Tau," pp. 5384-5388, Proceedings of the National Academy of Sciences of the USA, vol. 89, No. 12, Washington, DC (Jun. 1992). |